USFDA issues CRL for proposed biosimilar Insulin-R: Biocon - Newsdrum

Retrieved on: 2023-01-07 21:22:37

Tags for this article:

Life Sciences

Articles

Health

Biotechnology

Biocon

Companies based in Bangalore

Food and Drug Administration

Pharmaceutical industry

Biopharmaceutical

Biologics license application

Click the tags to see associated articles and topics

USFDA issues CRL for proposed biosimilar Insulin-R: Biocon - Newsdrum. View article details on HISWAI: https://www.newsdrum.in/business/usfda-issues-crl-for-proposed-biosimilar-insulin-r-biocon

Excerpt

Biotechnology major Biocon on Saturday said the US health regulator has issued a complete response letter for Biocon Biologics' application for ...

Article found on: www.newsdrum.in

View Original Article